APA (7th ed.) Citation

Csonka, D., Bruderer, S., Schultz, A., Soergel, M., Stepanova, R., Sabattini, G., & Perez-Ruixo, J. J. (2019). Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects. Clinical drug investigation, 39(12), 1223-1232. https://doi.org/10.1007/s40261-019-00857-7

Chicago Style (17th ed.) Citation

Csonka, Dénes, Shirin Bruderer, Armin Schultz, Marianne Soergel, Radka Stepanova, Giancarlo Sabattini, and Juan Jose Perez-Ruixo. "Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects." Clinical Drug Investigation 39, no. 12 (2019): 1223-1232. https://doi.org/10.1007/s40261-019-00857-7.

MLA (9th ed.) Citation

Csonka, Dénes, et al. "Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects." Clinical Drug Investigation, vol. 39, no. 12, 2019, pp. 1223-1232, https://doi.org/10.1007/s40261-019-00857-7.